University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor
Print this page
FONT SIZE
Home > Doctors > Kanade Shinkai

Kanade Shinkai, M.D.

Dermatologist

Dr. Kanade Shinkai is an attending physician in the Dermatology Clinic. She has expertise in dermatology of hospitalized, systemically ill patients. She sees patients with all types of skin disease but specializes in complex medical dermatology with a focus on autoimmune and autoinflammatory disorders of skin. Shinkai performs research on immunologic and inflammatory cutaneous diseases.

Clinics

Dermatology Clinic
1701 Divisadero St., Third and Fourth Floors
San Francisco, CA 94115
Phone: (415) 353–7800
Fax: (415) 353–7870

Hours: Monday to Friday, 8 a.m. – 5 p.m.

More about Kanade Shinkai

Education

UCSF School of Medicine 2004

Residencies

UCSF Medical Center, Dermatology 2008

Selected Research and Publications

  1. Scharschmidt TC, Amerson EH, Rosenberg OS, Jacobs RA, McCalmont TH, Shinkai K. Immune reconstitution reactions in human immunodeficiency virus-negative patients: report of a case and review of the literature. JAMA Dermatol. 2013 Jan 1; 149(1):74-8.
  2. Kamangar F, Shinkai K. Acne in the adult female patient: a practical approach. Int J Dermatol. 2012 Oct; 51(10):1162-74.
  3. Hansra NK, Shinkai K, Fox LP. Ethical issues in inpatient consultative dermatology. Clin Dermatol. 2012 Sep; 30(5):496-500.
  4. Kamangar F, McCalmont T, Shinkai K. Cutaneous metastasis of thyroid carcinoma mimicking Mondor disease. J Am Acad Dermatol. 2012 Aug; 67(2):e79-81.
  5. Shinkai K, Fox LP. What is your diagnosis? Inflamed molluscum contagiosum as a manifestation of immune reconstitution inflammatory syndrome. Cutis. 2012 May; 89(5):212, 219-20.
  6. Schulman JM, McCalmont TH, Shinkai K. Fulminant dermatomyositis with flagellate erythema. J Drugs Dermatol. 2011 Aug; 10(8):902-4.
  7. Hansra NK, Shinkai K. Cutaneous community-acquired and hospital-acquired methicillin-resistant Staphylococcus aureus. Dermatol Ther. 2011 Mar-Apr; 24(2):263-72.
  8. Pugashetti R, Shinkai K, Ruben BS, Grossman ME, Maldonado J, Fox LP. Calcium may preferentially deposit in areas of elastic tissue damage. J Am Acad Dermatol. 2011 Feb; 64(2):296-301.
  9. Hsiao JL, Antaya RJ, Berger T, Maurer T, Shinkai K, Leslie KS. Hidradenitis suppurativa and concomitant pyoderma gangrenosum: a case series and literature review. Arch Dermatol. 2010 Nov; 146(11):1265-70.
  10. Fox LP, Cotliar J, Hughey L, Kroshinsky D, Shinkai K. Hospitalist dermatology. J Am Acad Dermatol. 2009 Jul; 61(1):153-4.
  11. Shoo BA, Shinkai K, McCalmont TH, Fox LP. Xanthogranulomas associated with hematologic malignancy in adulthood. J Am Acad Dermatol. 2008 Sep; 59(3):488-93.
  12. Shinkai K, McCalmont TH, Leslie KS. Cryopyrin-associated periodic syndromes and autoinflammation. Clin Exp Dermatol. 2008 Jan; 33(1):1-9.
  13. Han MM, Pang J, Shinkai K, Franc B, Hawkins R, Aparici CM. Calciphylaxis and bone scintigraphy: case report with histological confirmation and review of the literature. Ann Nucl Med. 2007 Jun; 21(4):235-8.
  14. Voehringer D, Reese TA, Huang X, Shinkai K, Locksley RM. Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system. J Exp Med. 2006 Jun 12; 203(6):1435-46.
  15. Kilcline C, Shinkai K, Bree A, Modica R, Von Scheven E, Frieden IJ. Neonatal-onset multisystem inflammatory disorder: the emerging role of pyrin genes in autoinflammatory diseases. Arch Dermatol. 2005 Feb; 141(2):248-53.
  16. Shinkai K, Kilcline C, Connolly MK, Frieden IJ. The pyrin family of fever genes: unmasking genetic determinants of autoinflammatory disease. Arch Dermatol. 2005 Feb; 141(2):242-7.
  17. Voehringer D, Shinkai K, Locksley RM. Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. Immunity. 2004 Mar; 20(3):267-77.
  18. Shinkai K, Mohrs M, Locksley RM. Helper T cells regulate type-2 innate immunity in vivo. Nature. 2002 Dec 19-26; 420(6917):825-9.
  19. Baron JL, Gardiner L, Nishimura S, Shinkai K, Locksley R, Ganem D. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity. 2002 Apr; 16(4):583-94.
  20. Mohrs M, Blankespoor CM, Wang ZE, Loots GG, Afzal V, Hadeiba H, Shinkai K, Rubin EM, Locksley RM. Deletion of a coordinate regulator of type 2 cytokine expression in mice. Nat Immunol. 2001 Sep; 2(9):842-7.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.

Home • Terms of Use • Site Map • Contact Us       © 2002 - 2013 The Regents of The University of California